[Advances in the management of cervical lymphadenopathies of unknown primary; advances in diagnostic imaging and surgical modalities and new international staging system].

Related Articles

[Advances in the management of cervical lymphadenopathies of unknown primary; advances in diagnostic imaging and surgical modalities and new international staging system].

Bull Cancer. 2017 Dec 21;:

Authors: Troussier I, Klausner G, Morinière S, Blais E, Jean-Christophe Faivre, Champion A, Geoffrois L, Pflumio C, Babin E, Maingon P, Thariat J

Abstract
INTRODUCTION: Cervical lymphadenopathies of unknown primary represent 3 % of head and neck cancers. Their diagnostic work up has largely changed in recent years. This review provides an update on diagnostic developments and their potential therapeutic impact.
MATERIALS AND METHODS: This is a systematic review of the literature.
RESULTS: In recent years, changes in epidemiology-based prognostic factors such as human papilloma virus (HPV) cancers, advances in imaging and minimally invasive surgery have been integrated in the management of cervical lymphadenopathies of unknown primary. In particular, systematic use of PET scanner and increasing practice of robotic or laser surgery have contributed to increasing detection rate of primary cancers. These allow more adapted and personalized treatments. The impact of changes in the eighth TNM staging system is discussed.
CONCLUSION: The management of cervical lymphadenopathies of unknown primary cancer has changed significantly in the last 10 years. On the other hand, practice changes will have to be assessed.

PMID: 29275831 [PubMed - as supplied by publisher]

http://ift.tt/2BRXgAs